Endocrinologist Dr. Embress Mithil on the happy side effects of weight loss drugs
The new GLP-1 Vet-Loss Drugs are changing obesity treatment with health benefits in India. India’s top endocrinologist Dr. In an episode booked by Embrish Mithal, the effect of these drugs on diseases such as Alzheimer’s and cardiac conditions highlighted.
In short
- GLP-1 drugs cause muscle loss due to weight loss
- Rapid weight loss can cause loose skin, especially in older adults
- No evidence connects GLP-1 drugs with thyroid cancer risks
Drugs are exploding in the market, providing better results than traditional drugs, weighing new age. Top endocrinologist Dr. Embrish Mithal declined several aspects including the side -effects of these GLP -1 drugs in his recently published book The Wet Los Revolution in an episode of India Today.
He said that GLP-1 field-draws that belong to the class of GLP-1, target the same hormones in the body-have started exploding, have many new drugs with less and less side effects and will be easier to use.
While most cases have shown the loss of muscle as a major result of using GLP-1 drugs such as Tirzepatide or semaglutide, Dr. Mithil explains that losing muscles is a factor with weight loss.
“In the long run, if you are not following a healthy diet, you will be eliminated with significant muscle loss. And this is not due to weight loss drugs. Whenever we lose weight, we also lose muscles. If you lose 10 kg, you lose 2-3 kg of muscles. Now, if you want to ensure your diet, you want to ensure. Mithhal said.
He also shared that many people experience loose skin after taking these drugs. “When you lose weight rapidly, you lose subcutaneous fat. Especially in older people where the skin is relaxed anyway. If you suddenly lose weight, do not hydrate yourself well, do not eat the right kind of balanced diet, you get a little relaxation on that face, which has started calling people on the ozapic face.
In addition to gastrointestinal side-effects, nausea, and vomiting, Dr. Mithhal addressed concerns about thyroid cancer, stating that there is no evidence to connect the two.
He also explained the “Happy Side-Effects” of GLP-1 drugs. In addition to the growing body of evidence, how Semaglutide is associated with Alzheimer’s disease, Dr. Mithhal said that the benefits of drugs are increasing beyond weight loss.
“Evidence that they can help Alzheimer’s help in helping the brain help, and even for heart health, Parkinson’s disease. Cardiac events are reduced. Fatty liver is reduced. The progression of kidney disease is reduced. Syndrome).
Currently, most GLP-1 drugs are injected and expensive, limiting their access to India. However, new yoga and more research are in the way. Vegovi of Novo Nordisk and Eli Lily’s Mounaro, two blockbuster fats-busting drugs, diabetes and obesity are set to gain land in India to deal with the crisis.
“Remember, the GLP-1 area is simply exploding. There will be many new drugs with low and low side effects,” Dr. Dr. Mithhal says.